Aptamer Group PLC (APTA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Aptamer Group PLC (APTA) has a cash flow conversion efficiency ratio of -0.493x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-682.00K ≈ $-82.98 USD) by net assets (GBX1.38 Million ≈ $168.15 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Aptamer Group PLC to measure how many days the company can operate on defensive assets alone.
Aptamer Group PLC - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Aptamer Group PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Aptamer Group PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aptamer Group PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
HAVN LIFE SCIENCES INC.
F:5NP0
|
N/A |
|
Fusion Antibodies PLC
LSE:FAB
|
-0.792x |
|
Captivision Inc
NASDAQ:CAPT
|
0.085x |
|
ImagineAR Inc
F:GMS1
|
0.046x |
|
Northern Bear Plc
LSE:NTBR
|
0.121x |
|
Haydale Graphene Industries
LSE:HAYD
|
-0.398x |
|
Tekcapital plc
LSE:TEK
|
-0.012x |
|
Conygar Investment Co PLC
LSE:CIC
|
0.092x |
Annual Cash Flow Conversion Efficiency for Aptamer Group PLC (2019–2025)
The table below shows the annual cash flow conversion efficiency of Aptamer Group PLC from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see Aptamer Group PLC market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | GBX1.38 Million ≈ $168.15 |
GBX-2.00 Million ≈ $-243.46 |
-1.448x | +43.77% |
| 2024-06-30 | GBX887.00K ≈ $107.92 |
GBX-2.28 Million ≈ $-277.90 |
-2.575x | +80.74% |
| 2023-06-30 | GBX304.00K ≈ $36.99 |
GBX-4.06 Million ≈ $-494.47 |
-13.368x | -4431.75% |
| 2022-06-30 | GBX8.05 Million ≈ $979.57 |
GBX-2.38 Million ≈ $-288.97 |
-0.295x | +97.18% |
| 2021-06-30 | GBX105.00K ≈ $12.78 |
GBX-1.10 Million ≈ $-133.74 |
-10.469x | -3011.08% |
| 2020-03-31 | GBX245.81K ≈ $29.91 |
GBX-82.71K ≈ $-10.06 |
-0.336x | +64.16% |
| 2019-03-31 | GBX899.87K ≈ $109.49 |
GBX-844.93K ≈ $-102.80 |
-0.939x | -- |
About Aptamer Group PLC
Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and … Read more